BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This advanced composite hydrogel material features highly fluid ketoprofen-loaded ethosomes embedded within a semi-solid polymeric matrix template. The structural framework consists of an ultra-flexible ethosomal lipid matrix formulated with a high concentration of short-chain aliphatic alcohols (typically 20-45% ethanol) and high-purity phospholipids encapsulating the propionic acid derivative ketoprofen, entirely dispersed within a highly cross-linked viscoelastic network of a hydrophilic polymer hydrogel. This complex configuration coordinates an exceptionally fluid, ethanol-intercalated lipid vesicle matrix with a dense macroscopic mechanical barrier, altering the overall matrix density and passive mass transfer resistance to completely prevent drug crystallization and physical vesicle aggregation across variable laboratory testing setups.
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.